Chronic gastritis - An update

Best Practice and Research: Clinical Gastroenterology

Volumn 28, Issue 6, 2014, Pages 1031-1042

  Varbanova, Mariya ^a   Frauenschläger, Katrin ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Autoimmune gastritis; Gastritis; Helicobacter pylori; Pernicious anaemia

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; CYANOCOBALAMIN; HOST FACTOR; METRONIDAZOLE; PARIETAL CELL ANTIBODY; PROTON PUMP INHIBITOR; AUTOANTIBODY; AUTOANTIGEN;

ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL VIRULENCE; CHRONIC GASTRITIS; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTRITIS; GASTRITIS; GASTROINTESTINAL DISEASE; GROUPS BY AGE; HELICOBACTER PYLORI; HOST SUSCEPTIBILITY; HUMAN; PATHOGENESIS; PERNICIOUS ANEMIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; ANEMIA, PERNICIOUS; BLOOD; CHRONIC DISEASE; HELICOBACTER INFECTION; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; STOMACH PARIETAL CELL; VITAMIN B 12 DEFICIENCY;

ANEMIA, PERNICIOUS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PARIETAL CELLS, GASTRIC; VITAMIN B 12 DEFICIENCY;

EID: 84925225708     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2014.10.005     Document Type: Review

References (78)

1. Hsu PI, Lai KH, Hsu PN, Lo GH, Yu HC, Chen WC, et al. Helicobacter pylori infection and the risk of gastric malignancy. Am J Gastroenterol 2007;102: 725-30.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345: 784-9.
3. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: A meta-analysis. Am J Gastroenterol 2007;102: 1789-98.
4. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011;16(Suppl. 1): 1-9.
5. Zou QH, Li RQ. Helicobacter pylori in the oral cavity and gastric mucosa: A meta-analysis. J Oral Pathol Med 2011;40: 317-24.
6. Wex T, Venerito M, Kreutzer J, Gotze T, Kandulski A, Malfertheiner P. Serological prevalence of Helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010. Clin Vaccine Immunol CVI 2011;18: 2109-12.
7. Bauer S, Krumbiegel P, Richter M, Richter T, Roder S, Rolle-Kampczyk U, et al. Influence of sociodemographic factors on Helicobacter pylori prevalence variability among schoolchildren in Leipzig, Germany. A long-term follow-up study. Cent Eur J Public Health 2011;19: 42-5.
8. Mana F, Vandebosch S, Miendje Deyi V, Haentjens P, Urbain D. Prevalence of and risk factors for H. pylori infection in healthy children and young adults in Belgium anno 2010/2011. Acta Gastro Enterol Belg 2013;76: 381-5.
9. Posselt G, Backert S, Wessler S. The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal CCS 2013;11: 77.
10. Fujiya K, Nagata N, Uchida T, Kobayakawa M, Asayama N, Akiyama J, et al. Different gastric mucosa and CagA status of patients in India and Japan infected with Helicobacter pylori. Dig Dis Sci 2014;59: 631-7.
11. Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y, et al. Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 2002;186: 1621-30.
12. Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, et al. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006;130: 1181-90.
13. Ferreira RM, Machado JC, Leite M, Carneiro F, Figueiredo C. The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma. Histopathology 2012; 60: 992-8.
14. Figueiredo CA, Marques CR, Costa Rdos S, da Silva HB, Alcantara-Neves NM. Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: Friend or foe? World J Gastroenterol WJG 2014;20: 5235-43.
15. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94: 1680-7.
16. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection - The maastricht IV/Florence consensus report. Gut 2012;61: 646-64.
17. Hardbower DM, Peek Jr. RM, Wilson KT. At the bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol 2014 Aug;96(2): 201-12.
18. Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, et al. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun 2010;78: 845-53.
19. Kandulski A, Wex T, Kuester D, Peitz U, Gebert I, Roessner A, et al. Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGFbeta1. Helicobacter 2008;13: 295-303.
20. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996;20: 1161-81.
21. Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, et al. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol 2003;98: 1005-9.
22. Kodama M, Murakami K, Okimoto T, Fukuda Y, Shimoyama T, Okuda M, et al. Influence of proton pump inhibitor treatment on Helicobacter pylori stool antigen test. World J Gastroenterol WJG 2012;18: 44-8.
23. Zhang Y, Weck MN, Schottker B, Rothenbacher D, Brenner H. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: Evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev 2013;22: 821-6.
24. Cabrera de Leon A, Almeida Gonzalez D, Almeida AA, Gonzalez Hernandez A, Carretero Perez M, Rodriguez Perez Mdel C, et al. Factors associated with parietal cell autoantibodies in the general population. Immunol Lett 2012;147: 63-6.
25. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996;156: 1097-100.
26. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: Age-related progression from iron deficiency to cobalamin depletion. Blood 2006;107: 1673-9.
27. De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: A clinically oriented review. J Clin Endocrinol Metab 2008;93: 363-71.
28. Tozzoli R, Kodermaz G, Perosa AR, Tampoia M, Zucano A, Antico A, et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: A five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 2010;10: 80-3.
29. Karlsson FA, Burman P, Loof L, Mardh S. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach. J Clin Invest 1988;81: 475-9.
30. D'Elios MM, Bergman MP, Azzurri A, Amedei A, Benagiano M, De Pont JJ, et al. H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 2001;120: 377-86.
31. van Driel IR, Baxter AG, Laurie KL, Zwar TD, La Gruta NL, Judd LM, et al. Immunopathogenesis, loss of T cell tolerance and genetics of autoimmune gastritis. Autoimmun Rev 2002;1: 290-7.
32. Toh BH, Sentry JW, Alderuccio F. The causative H+/K+ ATPase antigen in the pathogenesis of autoimmune gastritis. Immunol Today 2000;21: 348-54.
33. De Maria R, Testi R. Fas-FasL interactions: A common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today 1998;19: 121-5.
34. Dickey W, Kenny BD, McMillan SA, Porter KG, McConnell JB. Gastric as well as duodenal biopsies may be useful in the investigation of iron deficiency anaemia. Scand J Gastroenterol 1997;32: 469-72.
35. Marignani M, Delle Fave G, Mecarocci S, Bordi C, Angeletti S, D'Ambra G, et al. High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: A prospective screening study. Am J Gastroenterol 1999;94: 766-72.
36. Fong TL, Dooley CP, Dehesa M, Cohen H, Carmel R, Fitzgibbons PL, et al. Helicobacter pylori infection in pernicious anemia: A prospective controlled study. Gastroenterology 1991;100: 328-32.
37. Lahner E, Annibale B. Pernicious anemia: New insights from a gastroenterological point of view.World J Gastroenterol WJG 2009;15: 5121-8.
38. Annibale B, Negrini R, Caruana P, Lahner E, Grossi C, Bordi C, et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 2001;6: 225-33.
39. Annibale B, Lahner E, Santucci A, Vaira D, Pasquali A, Severi C, et al. CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter 2007;12: 23-30.
40. Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+ eadenosine triphosphatase in human gastric autoimmunity. J Exp Med 2003;198: 1147-56.
41. Rugge M, Fassan M, Pizzi M, Zorzetto V, Maddalo G, Realdon S, et al. Autoimmune gastritis: Histology phenotype and OLGA staging. Aliment Pharmacol Ther 2012;35: 1460-6.
42. Cockburn AN, Morgan CJ, Genta RM. Neuroendocrine proliferations of the stomach: A pragmatic approach for the perplexed pathologist. Adv Anat Pathol 2013;20: 148-57.
43. Vanoli A, La Rosa S, Luinetti O, Klersy C, Manca R, Alvisi C, et al. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: The predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions. Hum Pathol 2013;44: 1827-37.
44. Suzuki K, Noda Y, Fujita N, Hirasawa D, Obana T, Sugawara T, et al. Clinicopathological study on endocrine cell micronests associated with early gastric cancer. Intern Med 2013;52: 1311-6.
45. Nguyen TL, Khurana SS, Bellone CJ, Capoccia BJ, Sagartz JE, Kesman Jr. RA, et al. Autoimmune gastritis mediated by CD4+ T cells promotes the development of gastric cancer. Cancer Res 2013;73: 2117-26.
46. Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011;117: 1163-71.
47. Mellemkjaer L, Gridley G, Moller H, Hsing AW, Linet MS, Brinton LA, et al. Pernicious anaemia and cancer risk in Denmark. Br J Cancer 1996;73: 998-1000.
48. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, et al. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993;71: 745-50.
49. Karlson BM, Ekbom A, Wacholder S, McLaughlin JK, Hsing AW. Cancer of the upper gastrointestinal tract among patients with pernicious anemia: A case-cohort study. Scand J Gastroenterol 2000;35: 847-51.
50. Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev 2014;13: 459-62.
51. Soykan I, Yakut M, Keskin O, Bektas M. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis. Digestion 2012;86: 20-6.
52. Bizzaro N, Antico A. Diagnosis and classification of pernicious anemia. Autoimmun Rev 2014;13: 565-8.
53. Lechner K, Fodinger M, Grisold W, Puspok A, Sillaber C. Vitamin B12 deficiency. New data on an old theme. Wien klin Wochenschr 2005;117: 579-91.
54. Miceli E, Lenti MV, Padula D, Luinetti O, Vattiato C, Monti CM, et al. Common features of patients with autoimmune atrophic gastritis. Clin Gastroenterol Hepatol 2012;10: 812-4.
55. Annibale B, Lahner E, Negrini R, Baccini F, Bordi C, Monarca B, et al. Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis. World J Gastroenterol WJG 2005;11: 5351-7.
56. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: Influence of patient age and race. Clin Exp Immunol 1992;89: 74-7.
57. Davidson RJ, Atrah HI, Sewell HF. Longitudinal study of circulating gastric antibodies in pernicious anaemia. J Clin Pathol 1989;42: 1092-5.
58. Lahner E, Norman GL, Severi C, Encabo S, Shums Z, Vannella L, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 2009;104: 2071-9.
59. Sari R, Ozen S, Aydogdu I, Yildirim B, Sevinc A. The pathological examinations of gastric mucosa in patients with Helicobacter pylori-positive and-negative pernicious anemia. Helicobacter 2000;5: 215-21.
60. Park JY, Lam-Himlin D, Vemulapalli R. Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc 2013;77: 284-92.
61. Okuda K. Discovery of vitamin B12 in the liver and its absorption factor in the stomach: A historical review. J Gastroenterol Hepatol 1999;14: 301-8.
62. Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood 2008;112: 2214-21.
63. Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2005 Jul;20(3): CD004655.
64. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): Guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44: 74-94.
65. Kokkola A, Sjoblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Jarvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 1998;33: 88-92.
66. Lahner E, Caruana P, D'Ambra G, Ferraro G, Di Giulio E, Delle Fave G, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: When should it be done? Gastrointest Endosc 2001;53: 443-8.
67. Sjoblom SM, Sipponen P, Jarvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut 1993;34: 28-32.
68. Uygun A, Kadayifci A, Polat Z, Yilmaz K, Gunal A, Demir H, et al. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors. J Surg Oncol 2014;109: 71-4.
69. Kaltsas G, Grozinsky-Glasberg S, Alexandraki KI, Thomas D, Tsolakis AV, Gross D, et al. Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms. Clin Endocrinol 2014 Aug;81(2): 157-68.
70. Wu TT, Hamilton SR. Lymphocytic gastritis: Association with etiology and topology. Am J Surg Pathol 1999;23: 153-8.
71. Diamanti A, Maino C, Niveloni S, Pedreira S, Vazquez H, Smecuol E, et al. Characterization of gastric mucosal lesions in patients with celiac disease: A prospective controlled study. Am J Gastroenterol 1999;94: 1313-9.
72. Nielsen OH, Riis LB, Danese S, Bojesen RD, Soendergaard C. Proximal collagenous gastroenteritides: Clinical management. A systematic review. Ann Med 2014 Aug;46(5): 311-7.
73. Brain O, Rajaguru C, Warren B, Booth J, Travis S. Collagenous gastritis: Reports and systematic review. Eur J Gastroenterol Hepatol 2009;21: 1419-24.
74. Hijaz NM, Septer SS, Degaetano J, Attard TM. Clinical outcome of pediatric collagenous gastritis: Case series and review of literature. World J Gastroenterol WJG 2013;19: 1478-84.
75. Ko HM, Morotti RA, Yershov O, Chehade M. Eosinophilic gastritis in children: Clinicopathological correlation, disease course, and response to therapy. Am J Gastroenterol 2014 Aug;109(8): 1277-85.
76. Sakuraba A, Iwao Y, Matsuoka K, Naganuma M, Ogata H, Kanai T, et al. Endoscopic and pathologic changes of the upper gastrointestinal tract in Crohn's disease. BioMed Res Int 2014;2014: 610767.
77. Freeman HJ. Age-dependent phenotypic clinical expression of Crohn's disease. J Clin Gastroenterol 2005;39: 774-7.
78. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Clinical aspects of Crohn's disease of the upper gastrointestinal tract: A comparison with distal Crohn's disease. Am J Gastroenterol 1997;92: 1467-71.